NCT00842049

Brief Summary

Subarachnoid haemorrhage affects approximately 8000 people per year in the UK. The average age of a patient with subarachnoid haemorrhage is 50 years, although it is often seen in younger people (25-45 years). Despite modern medicine, the death and disability rate remains high both from the initial bleed and from the associated complications such as vasospasm. This is characterised by neurological impairment seen following the bleed. Despite modern treatment this is still associated with a poor outcome. This has significant implications due to the long term intensive neuro-rehabilitation these patients will require. A recent study has shown that placing a small drain in the lower back following a subarachnoid haemorrhage may reduce the chance of vasospasm occurring and result in a better outcome. This trial was not optimally performed and so a trial is needed to look at this in more detail. The investigators have set up such a trial in our neurosurgical unit. If the investigators confirm that there is an improvement in patient outcome, it will change our practice in the future.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Nov 2006

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2006

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

February 11, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 12, 2009

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
Last Updated

December 22, 2023

Status Verified

December 1, 2023

Enrollment Period

3.7 years

First QC Date

February 11, 2009

Last Update Submit

December 19, 2023

Conditions

Keywords

Subarachnoid haemorrhageAneurysmCerebrospinal fluid drainage

Outcome Measures

Primary Outcomes (1)

  • Incidence of delayed ischaemic neurological deficit

    Within 21 days of haemorrhagic ictus

Secondary Outcomes (4)

  • Modified Rankin Score

    10 days and 6 months following haemorrhagic ictus

  • Incidence of cerebrospinal fluid shunting

    Within 12 months of haemorrhagic ictus

  • Incidence of completed infarct secondary to delayed ischaemic neurological deficit

    Within 21 days of ictus

  • Incidence of cerebrospinal fluid infection secondary to lumbar drainage

    Within 8 weeks of removal of lumbar drain

Study Arms (2)

Study

EXPERIMENTAL

Insertion of lumbar drain

Device: Lumbar Drain (Medtronic lumbar drainage system)

Control

OTHER

Normal clinical management without lumbar drain

Other: No lumbar drain

Interventions

Insertion of lumbar drain to drain cerebrospinal fluid

Also known as: Medtronic lumbar drainage system
Study

No lumbar drain

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aneurysmal subarachnoid haemorrhage.
  • Recruitment prior to day three post-haemorrhage.
  • Written informed consent or relative assent given.
  • WFNS grade 1-3.
  • Fisher grade 2, 3 and 4 (without space occupying haematoma) on initial CT scan.
  • No intraventricular haemorrhage, space occupying haematoma or other contra-indication to lumbar puncture.

You may not qualify if:

  • Non-aneurysmal subarachnoid haemorrhage.
  • Delayed presentation / recruitment (after day three post-haemorrhage)
  • Written informed consent or relative assent denied or unobtainable.
  • WFNS grade 4 or 5.
  • Fisher grade 1 on initial CT scan.
  • Intraventricular haematoma obstructing ventricular outflow.
  • Intracranial haematoma with mass effect.
  • Bleeding diathesis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leeds General Infirmary

Leeds, West Yorkshire, LS1 3EX, United Kingdom

Location

Related Publications (2)

  • Klimo P Jr, Kestle JR, MacDonald JD, Schmidt RH. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg. 2004 Feb;100(2):215-24. doi: 10.3171/jns.2004.100.2.0215.

    PMID: 15086227BACKGROUND
  • Al-Tamimi YZ, Bhargava D, Feltbower RG, Hall G, Goddard AJ, Quinn AC, Ross SA. Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS). Stroke. 2012 Mar;43(3):677-82. doi: 10.1161/STROKEAHA.111.625731. Epub 2012 Jan 26.

MeSH Terms

Conditions

Subarachnoid HemorrhageAneurysmCerebrospinal Fluid Leak

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsNeurologic ManifestationsCraniocerebral TraumaTrauma, Nervous SystemSigns and SymptomsWounds and Injuries

Study Officials

  • Yahia Al-Tamimi, MCChB(Hons)

    Leeds Teaching Hospital NHS Trust

    PRINCIPAL INVESTIGATOR
  • Stuart Ross, FRCS(SN)

    Leeds Teaching Hospital NHS Trust

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2009

First Posted

February 12, 2009

Study Start

November 1, 2006

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

December 22, 2023

Record last verified: 2023-12

Locations